Tesamorelin vs Sermorelin — Peptide Comparison

Tesamorelin vs Sermorelin — Peptide Comparison Tesamorelin vs Sermorelin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Tesamorelin 1–2 mg Sermorelin 100–300 mcg Frequency Once daily Administration Subcutaneous injection Cycle Length 12+ weeks Onset Speed Moderate (1-2 weeks) Evidence Level Strong human trials (Phase 3 or FDA approved) Moderate human trials (Phase 1-2) Efficacy Visceral Fat Reduction Metabolic Health Natural GH Boost GH Optimization Sleep Quality Body Composition Technical Data Molecular Formula C221H366N72O67S Molecular Weight 5135.86 g/mol Half-Life 26-38 minutes Bioavailability ~100% (subcutaneous injection) CAS Number 218949-48-5 C149H246N44O42S 3357.9 g/mol 10-20 minutes High when injected subcutaneously; degraded orally 86168-78-7 Protocols standard 2 mg (1.4 mg with Egrifta SV/WR F8 formulation) 26 weeks, continued long-term for sustained effect FDA-approved dose for HIV-associated lipodystrophy; full dose from day one with no titration [6]. Pivotal phase 3 trials used 2 mg daily [1]. starting 100-200 mcg Once daily at bedtime 4-6 weeks Lower nightly dose used in practice; GHRH(1-29) nightly injections raised GH/IGF-1 in older adults [2][3]. 200-300 mcg 3-6 months Common adult maintenance dose; twice-daily GHRH(1-29) reversed age-related GH/IGF-1 decline in men [1][2]. Applications People with Stubborn Visceral Fat If you carry your weight around your midsection—the deep belly fat that wraps around your organs—tesamorelin is specifically designed for you. Unlike weight loss drugs, it targets visceral fat while preserving the normal subcutaneous fat that's healthy to have. HIV Patients with Lipodystrophy Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy—the abnormal fat accumulation in the belly that antiretroviral medications can cause. It's the only treatment proven to help this condition, reducing both the physical and psychological burden. Those Concerned About Metabolic Health Visceral fat isn't just cosmetic—it's metabolically dangerous, linked to heart disease, diabetes, and inflammation. By reducing visceral fat, tesamorelin also improves triglycerides, cholesterol ratios, and may help protect your liver from fatty liver disease. Adults Wanting Natural GH Stimulation Unlike synthetic growth hormone injections, tesamorelin works WITH your body's natural systems. It tells your pituitary to release more of YOUR OWN growth hormone, maintaining normal feedback loops and reducing the risks associated with supraphysiological GH levels. Adults Experiencing Age-Related GH Decline After age 30, your growth hormone production naturally declines about 14% per decade. Sermorelin helps restore more youthful GH levels by stimulating your own pituitary rather than shutting it down with external hormones. It's like giving your hormone system a gentle nudge back to where it used to be. Body Composition Optimizers If you're struggling to lose stubborn belly fat or build lean muscle despite diet and exercise, sermorelin can help shift your body composition over time. Studies show it increases lean mass and reduces fat, especially in older adults whose natural GH has declined. Sleep Quality Seekers Growth hormone is intimately tied to deep, restorative sleep. By enhancing your natural nighttime GH pulses, sermorelin often improves sleep quality as a welcome side effect. Many users report falling asleep faster and waking more refreshed. Those Wanting a Safer Alternative to HGH Direct HGH injections bypass your body's feedback system and can suppress your own production. Sermorelin works differently—it asks your pituitary to make more GH naturally. This preserves your body's regulatory mechanisms and carries a lower risk of side effects. Safety Profile Common Injection site reactions Joint pain (arthralgia) Muscle pain (myalgia) Peripheral edema Uncommon Carpal tunnel symptoms Elevated blood glucose Serious Severe allergic reaction Worsening diabetes Facial flushing Headache Sleepiness or drowsiness Nausea Hyperactivity or difficulty sleeping Research Status FDA Status FDA approved for other use Safety Overview Tesamorelin has a strong safety profile backed by FDA approval and multiple large Phase 3 clinical trials involving over 800 patients. The most common issues are injection site reactions and the typical side effects of elevated growth hormone (joint pain, fluid retention). Glucose metabolism should be monitored as some patients experience increased blood sugar. Long-term cardiovascular safety data is still being collected, which is why the FDA recommends reassessing treatment if visceral fat doesn't reduce. Contraindications xActive malignancy or history of cancer (pituitary tumors especially) xKnown hypersensitivity to tesamorelin or mannitol xPregnancy xDisruption of the hypothalamic-pituitary axis from conditions like hypophysectomy or pituitary tumor surgery Sermorelin has an excellent safety profile backed by FDA approval history and decades of clinical use. Unlike direct HGH, it works through your body's natural feedback mechanisms, which inherently limits excessive hormone levels. Side effects are generally mild and transient—mostly injection site reactions and occasional flushing. The peptide was FDA-approved in 1997 for pediatric use and is one of the most well-studied growth hormone secretagogues available. xActive cancer or history of cancer xPregnancy or breastfeeding xKnown allergy to sermorelin or any peptide components xPituitary tumors or other pituitary disorders xDiabetic retinopathy Decision Guide Choose Tesamorelin if... Reducing visceral abdominal fat Improving metabolic health markers Supporting natural growth hormone production Addressing HIV-associated lipodystrophy Choose Sermorelin if... Anti-aging and vitality Body composition improvement Sleep quality enhancement Exercise recovery